Investigating the in vivo effects of the human adipose tissue-derived stem cell transplantation and bromelain in myelin regeneration Authors: Sharare Rahnama, Nazem Ghasemi Published: 2026 ABSTRACT Background and purpose:Natural compounds combined with human adipose-derived stem cell (hADSCs) transplantation could be considered an effective treatment for multiple sclerosis (MS). In the present study, the effects of bromelain administration in combination with hADSCs transplantation were evaluated for oligodendrocyte differentiation, myelin tissue regeneration, and improvement of motor function.Experimental approach:After inducing an MS mouse model, the mice were randomly divided into 4 groups: MS, MS + bromelain, MS + stem cell, and MS + bromelain + stem cell. Besides, 16 mice were designated for the control and sham groups. Finally, the behavioral test is used to evaluate motor function and motor defects. Furthermore, immunofluorescent staining was used to evaluate the cell markers. The serum levels of IgG, as well as inflammatory and anti-inflammatory factors, were assessed using an ELISA test.Findings/Results:The mean percentages of Olig2- and Mog-positive cells, myelin density, and the serum levels of IL-10 and TGF-β were significantly higher in the treated groups than in the MS group. However, the serum levels of IL-17 and IFN-γ in the MS group were significantly higher compared to the other groups. Also, the serum level of IgG in the MS group was significantly higher than in the other groups.Conclusion and implications:It can be said that hADSCs transplantation, along with bromelain administration, is able to increase myelination and improve balance function. Therefore, the use of these agents could be a fundamental step towards finding a suitable method for the treatment of neurodegenerative diseases. INTRODUCTION Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system (CNS) and causes mental and physical disabilities, especially in young people(12). This abnormal condition is characterized by several focal points of demyelination in the white matter of the CNS, which is associated with secondary neuroaxonal degeneration(345). MS is usually diagnosed between the ages of 20 and 40 and is three times more likely to occur in women than in Men(6). The exact cause of MS disease has not yet been determined, but various factors are involved in the development of this disease, which can be attributed to a person’s genetic predisposition and environmental factors such as viral and bacterial factors, especially Epstein-Barr virus (EBV), human herpes virus type 6, and Mycoplasma pneumoniae(7), smoking(8), vitamin D deficiency(9), heavy metal contact, and ultraviolet (UV) radiation contact(10). MS leads to neurological disabilities in the autonomic and sensorimotor systems, resulting in problems such as visual disturbances, ataxia, fatigue, and mental disorders(11). Early treatment for MS disease is based on the use of immunomodulator agents such as interferon beta (IFN-β), which not only has no effect on stopping MS but also has harmful immune complications and does not help much to repair(12). Today, advances have been made in the treatment of diseases caused by the destruction of myelin using stem cell transplants and the use of natural compounds by researchers. Human adipose-derived stem cells (hADSCs) are a specific population of stem cells that are suitable for cell-based treatment in MS due to their particular characteristics, such as the ability to differentiate into other cell types(13), especially oligodendrocyte cells, a lack of immune reactions and transplant rejection(1415), easy access, and strong immune-modulating effects(16). These cells are a special type of immune-privileged cell that lacks the expression of major histocompatibility complex (MHC) class II molecules. Therefore, these cells can be used as allografts without provoking immune responses and graft rejection(1718). Transplantation of these cells alone has not produced significant results in the treatment of the disease, and it seems that the use of a supplement with cell transplantation will lead to improved results. Today, animal studies in MS use a variety of models, including the cuprizone model, which is a simple model for studying demyelination, remyelination, the death processes of oligodendrocytes, and innate inflammatory responses of the brain(19). Cuprizone, or oxalic acid, as a copper chelator, disrupts the energy metabolism of oligodendrocytes and leads to their apoptosis, inducing the destruction of myelin in the mouse brain(20). Cuprizone-induced demyelination exhibits features similar to those seen in patients with MS(21). Specific surface markers of oligodendrocyte cells are used to investigate cell death. The three main proteins involved in the axon myelination process include the myelin basic protein (MBP), the myelin oligodendrocyte glycoprotein (Mog), and the oligodendrocyte transcription factor 2 (Olig2). These factors are used in immunohistochemical methods to check myelin density or to check mature and immature myelin cells(22). Some natural compounds with neuroprotective, anti-inflammatory, and immunomodulatory effects can reduce the toxic effects caused by environmental pathogens(23). Bromelain is a water-soluble proteolytic and polymer enzyme obtained commercially from the fruit or pineapple stalks(24). It is a natural compound derived from pineapple that has indicative antioxidant and anti-inflammatory effects and inhibits oxidative stress(24). Bromelain can be absorbed into the body without losing proteolytic activity and causing significant side effects(25). Peptides derived from this substance, after digestion by various proteases of the gastrointestinal tract, can easily cross the blood-brain barrier(26). Some experimental models have shown that bromelain can significantly increase the activity of antioxidant enzymes and inhibit oxidative stress(27). So it can have protective effects on the placenta by reducing oxidative stress and increasing the expression of transcription factors(1415). It can also prevent oxidant damage and cell death by removing oxygen radicals(28). Therefore, bromelain is a dietary supplement that can be used as an alternative to nonsteroidal anti-inflammatory drugs and as a helper in the treatment of chronic, malignant, and autoimmune inflammatory diseases(29). Since immunomodulation and inflammation suppression play a major role in promoting cell differentiation, it is better to use cell sources and compounds that can have the aforementioned properties for cell therapy. ADSCs have anti-inflammatory and immunomodulatory effects similar to those of the bromelain compound, and both of them can cross the blood-brain barrier. Therefore, the use of these two compounds could have high synergistic effects. On the other hand, bromelain, since it is available and also water-soluble, and the proteases resulting from its digestion easily cross the blood-brain barrier, can support the differentiation process of oligodendrocyte cells from the immature stage to mature cells. Therefore, the simultaneous use of these two sources was assessed for the first time to investigate oligodendrocyte differentiation and improve the remyelination process in the CNS. MATERIALS AND METHODS Research design This experimental study was conducted in 2024 at the animal nest of Isfahan University of Medical Sciences. The study protocol was approved by the Research Ethics Committee of the Isfahan University of Medical Sciences (Ethic No. IR.MUI.AEC.1402.073). Isolation and culture of hADSCs After obtaining consent from young female patients (aged 20 to 40 years and without chronic diseases) for liposuction surgery, subcutaneous adipose tissue was collected and transferred to the cell culture laboratory under sterile conditions. Cell culture was performed according to the previous research(19). Briefly, the adipose tissue was washed with phosphate-buffered saline (PBS; Sigma-Aldrich, UK, 806552) several times, and then digested mechanically and enzymatically. Collagenase type I 0.075% (Sigma-Aldrich, UK, SCR103) was used for enzymatic digestion (for 30 min), then to stop enzyme activity, Dulbecco’s modified Eagle’s medium (DMEM/F12; Bioidia, BI1027) containing 10% fetal bovine serum (FBS; Gibco, 10270106) was added to the samples. The suspension was centrifuged at 1400 rpm for 10 min, then the supernatant was decanted, and again, the pellets were placed in DMEM/F12, 10% FBS, and 1% penicillin/streptomycin (Bioidia, BI1036) and cultured in an incubator with a temperature of 37 °C and 5% CO2, humidified. Until the confluency of the cells reached about 80%, the medium was replaced every three days for two weeks. After this, cells were separated with 0.25% trypsin and 0.02% ethylenediaminetetraacetic acid (EDTA; Bioidia, BI-1601). In this study, hADSCs obtained from passage 3 were used for cell culture and transplantation. Characterization of isolated hADSCs Demonstrating the stem cell nature of a cell population necessitates rigorous validation. Common approaches include their ability to adhere to the bottom of cell culture flasks, their ability to differentiate into different cell lineages, and the expression of specific markers. In this study, the expression of markers was examined using flow cytometry. To this end, the cells were washed and then incubated with different fluorescein isothiocyanate (FITC) or phycoerythrin-conjugated antibodies against CD90, CD44, CD14, and CD45 for 30 min. Finally, flow cytometry was done with a FACScan flow cytometer (Becton-Dickinson, San Jose, CA), and the mean percentage of CD-positive cells was determined(1930). hADSCs PKH26 labeling Before cell transplantation, PKH26 was used as a red fluorescent color (Sigma-Aldrich, MINI26) to label hADSCs according to the manufacturer’s protocol. To this end, after collecting 14 × 106 stem cells and washing with PBS, pkh26 was added to the samples for 2 min. After this time, the cell labeling stage was stopped with 1% BSA (Sigma Aldrich A2153), and the cell washing was done with DMEM/F12. Using a fluorescent microscope, hundreds of cells were counted in several different fields, and the average percentage of indicated cells was determined to ensure the labeling method. Induction of the demyelination model by cuprizone and animal grouping In this study, 60 female C57BL/6 mice weighing 25-20 g and aged approximately 8 weeks were used. Animals were kept in an animal shelter under light/dark cycles and at a stable room temperature (23 ± 2 °C) with free access to water and food. To induce an animal model of MS, cuprizone (bis-cyclohexanone oxaldihydrazone; Sigma-Aldrich Inc. C9012), which was mixed in corn oil, was administered to each mouse at a dose of 400 mg/kg(3132) per day for 5 weeks. To this end, 44 mice were subjected to gavage with cuprizone. After conducting a hanging wire test, 12 mice were excluded from the study, and thirty-two mice, which had significant or slight motor damage, were randomly divided into 4 groups (8 mice each)(3132), including MS control (no intervention), bromelain group (treated daily with 40 mg/kg(3334) bromelain for four weeks), stem cell group, (0.2 mL of PBS containing 1 × 106 hADSCs injected into the caudal vein at the first day after grouping the mice), bromelain + stem cell group, (0.5 mL of PBS containing 1 × 106 hADSCs were injected into the caudal vein at the first day after grouping the mice, as well as bromelain at 40 mg/kg daily for four weeks). It should be noted that 16 mice were randomly divided into control and sham groups. Thus, in the healthy control group, the mice were maintained without any intervention, and in the sham group, the mice were gavage with 200 μL of corn oil for 4 weeks. Immunofluorescence staining Immunofluorescence staining was used to evaluate the levels of myelin glycoprotein oligodendrocyte (mature oligodendrocyte marker (Mog)), oligodendrocyte transcription factor (immature oligodendrocyte marker (Olig2)), and myelin basic protein (myelin marker (MBP)), and was based on previous studies(353637). At the end of the ninth week, the mice were anesthetized and sacrificed using ketamine/xylazine, and cardiac perfusion was performed using normal saline and 4% formaldehyde to fix the brain tissue. The brains were then removed from the skull and re-fixed with the same fixative (4% formaldehyde) for 24 h. After tissue processing, sample deparaffinization and antigen retrieval were carried out by the heating method for 11 min at 120 °C. To reduce the background color, the antigen was blocked by 10% goat serum (Sigma-Aldrich, USA, G9023) at room temperature for 30 min. Next, antibody incubation was carried out at 4 °C overnight using primary antibodies, including rabbit anti-Mog (1:1000; Abcam, ab32760), rat anti-MBP (1:1000; Abcam, ab7349, Cambridge, MA, USA), and rabbit anti-Olig2 (1:1000; Abcam, ab109186). In the subsequent step, the sections were washed three times using Tris buffer saline (TBS) and then incubated with goat anti-rabbit secondary antibody FITC (1:500; Abcam, ab6717, Cambridge, MA, USA) and goat anti-rat secondary antibody FITC (1:500, Abcam, ab6840, Cambridge, MA, USA) at room temperature, respectively, for 1 h. To stain the cell nuclei, 4’, 6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich, D9542) was added to the samples for 2 min. In the end, the samples were examined with a fluorescence microscope (Olympus, BX51, Japan). Finally, at least 200 cells in 5 fields were randomly selected by a laboratory specialist who was not affiliated with the research team and were examined to determine the percentage of Mog and Olig2-positive cells. Also, the average myelin density was calculated using the ImageJ software. Hanging wire test This behavioral test is based on the integrity of muscle function and is used to evaluate motor function and motor defects in rodent models with neurodegenerative disorders. This method measured and reported the time that the animal could hang from a wire with its forepaws(3738). Briefly, mice were suspended from a metal wire (90 cm in length, 2 mm in diameter, and 50 cm in height), and the mean latency to fall was recorded for 300 s. This test was performed daily from one week before the induction of the MS model until the end of the study. ELISA Test This method was used to assess serum levels of immunoglobulin G (IgG; AB_2314636, Helmholtz Zentrum Munchen (Service Platform for monoclonal Antibodies), Germany), as well as inflammatory and anti-inflammatory factors. In accordance with the studies, the washing buffer (KPG-WB, Karmaniaparsgen, Iran) and the Avidin horseradish peroxidase (HRP) solution (KPG-HA, Karmaniaparsgen, Iran) were prepared according to company protocols. After that, 50 μL of standards number 1 to 4 (KPGMIL2 NS1-4, Karmaniaparsgen, Iran) were added to the first to fourth wells, which were already coated, and the fifth well was considered for blank (step 1). In the following, 50 μL of the sample was added to the remaining wells and incubated for 50 min on a shaker at 200 RPM in the room (step 2). After incubation, the plates were washed 3 times using the washing solution (step 3). It should be noted that all solutions and buffers must be completely removed during the washing step. Then, 50 μL of conjugated antibody (Detection ab, KPG- MIL2D, Karmaniaparsgen, Iran) was added to all wells except for the blank and incubated for 50 min on a shaker at 200 RPM in the room (step 4). After incubation, the plates were washed 3 times using the washing solution (step 5). In the next step, 50 μL of HRP-Avidin solution was added to all wells except for the blank and incubated for 50 min on a shaker at 200 RPM (step 6). After incubation, the plates were washed 5 times using the washing solution (step 7). Thereafter, 50 μL of substrate was added to all wells and incubated for 15 min (step 8). Eventually, 2 μL of stop solution (KPG-ST, Karmaniaparsgen, Iran) was added to all wells (step 9), and the absorbance of the samples was measured with an ELISA reader (BioTek Agilent Technologies, USA) at a wavelength of 450 nm. The concentration of the samples was then calculated using the equation of the standard curve. It is worth mentioning that the standard solution should not be left outside of -20 °C for a long time, and the HRP-Avidin solution should be freshly prepared. In addition, to ensure the accuracy of the finding, each measurement was repeated three times(3940). Statistical analysis All data were analyzed using SPSS software version 25.0 (SPSS Inc., Chicago, Illinois, USA). After data normalization, one-way analysis of variance (ANOVA) followed by Tukey’s test was used, and the results are reported as mean ± SEM. P-values < 0.05 were considered statistically significant. RESULTS Characterization and labeling of hADSCs hADSCs before labeling exhibited a fibroblast-like morphology, which confirms their mesenchymal nature (Fig. 1A). After cell labeling by PKH26, the results revealed that approximately 85% of the hADSCs were labeled by PKH26 (Fig. 1B). In addition, flow cytometry results demonstrated that a high percentage of isolated cells expressed stem cell-specific surface markers and a very low percentage of them expressed specific hematopoietic cell markers. Of the total number of cells examined, only 1 to 3% of hADSCs were positive for CD14 and CD45 markers (hematopoietic cell markers) (Fig. 2B), and 93% of them expressed the CD44 marker (stem cell marker) (Fig. 2C), and 95% of them expressed the CD90 marker (Fig. 2D). Appearance of hADSCs before and after cell labeling with PKH26. (A) hADSCs after passage have a spindle-shaped appearance and adhere to the bottom of the flask. (B) PKH26-labeled cells, seen under a fluorescent microscope in red, and the nuclei of the cells stained with DAPI in blue. hADSCs, Human adipose-derived stem cells. Characterization of isolated hADSCs. (A) Unstained cells, Flow cytometry of hADSCs demonstrated that (B) 1 to 3% of hADSCs were positive for CD14 and CD45 markers (hematopoietic cell markers); and (C) 93% of them expressed the CD44 marker (stem cell markers); and (D) 95% of them expressed the CD90 marker. hADSCs, Human adipose-derived stem cells. Hanging wire test results Behavioral test results from the hanging wire test showed a significant decrease in the time of latency to fall in the cuprizone group compared to the control and sham groups (P <0.001) (Fig. 3A). In addition, four weeks after cell transplantation and bromelain administration, a significant increase in the time of latency to fall was observed in the treated groups. As shown in Fig. 3, a significant increase in latency to fall in the MS/Bromelain and MS/Stem groups was seen compared to the MS group (P < 0.05). In addition, in the MS/Stem/Bromelain group, a significant increase was seen compared to the MS group (P < 0.01) (Fig. 3B). Wire test to evaluate hanging time (A) before stem cell treatment and (B) after stem cell treatment. The data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant differences compared to the MS group. MS, Multiple sclerosis. The effect of bromelain and hADSCs on demyelination and oligodendrogenesis The results of the immunohistochemistry technique showed that the mean percentage of Olig2-positive cells increased in treated groups, significantly in MS/Stem and MS/Stem/Bromelin groups compared to the MS group (Figs. 4A and 5). In addition, the mean percentage of Mog-positive cells increased significantly in all treated groups compared to the MS group (Figs. 4B and 6). The average density of myelin was calculated to assess the demyelination/remyelination rate. Thus, five fields were selected from the corpus callosum (CC) region of the brain, and the average density of myelin was calculated using one of the specific myelin markers (MBP; Fig. 7). The results showed that the density of myelin in the CC region in all treated groups, MS/Stem, MS/Bromelain, and MS/Stem/Bromelain groups was significantly higher compared to the MS group (Fig. 6). In addition, the mean percentage of Olig2- and Mog-positive cells, and the density of myelin were significantly higher in the control and sham groups than in the cuprizone group (MS). Moreover, the evaluation of oligodendrocyte differentiation in the stem cell receiving groups showed that PKH26/Olig2 positive and PKH26/Mog positive cells were significantly higher in MS/Stem/Bromelain (13.2 ± 0.8 and 11.1 ± 0.9, respectively for Olig2 and Mog) in comparison to MS/Stem group (7.4 ± 0.7 and 6.3 ± 0.4, respectively for Olig2 and Mog) (Figs. 5A and B, 6A and B). The mean percentage of (A and B) Olig2, Mog positive cells, and (C) myelin density in stained corpus callosum sections. The results are presented as the mean ± SEM, n = 8 in each group. *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant differences compared to the MS group. MS, Multiple sclerosis; Olig2, oligodendrocyte transcription factor; Mog, myelin oligodendrocyte glycoprotein. (A) Immunohistochemical staining of Olig2-positive cells in stained corpus callosum sections. (B) The mean percentage of Olig2-positive cells (green) increased in the bromelain group. In addition, the PKH26/Olig2 positive labeled cells (red) were higher in the MS/Stem and MS/Stem/Bromelain groups compared to the MS group. The results are presented as the mean ± SEM, n = 8. *P < 0.05 indicates a significant difference compared to the MS/Stem group. DAPI (blue) was used for nuclear counterstaining. MS, Multiple sclerosis; DAPI, 4’, 6-diamidino-2-phenylindole; Olig2, oligodendrocyte transcription factor. Immunohistochemical staining of Mog-positive cells. The mean percentage of Mog-positive cells (green) increased in all treated groups compared to the MS group. The PKH26-labeled cells (hADSCs) were in red, and DAPI (blue) was used for nuclear counterstaining. The results are presented as the mean ± SEM, n = 8. *P < 0.05 indicates a significant difference compared to the MS/Stem group. MS, Multiple sclerosis; Mog, myelin oligodendrocyte glycoprotein; DAPI, 4’, 6-diamidino-2-phenylindole. Immunohistochemical staining of the MBP-positive marker. The mean of myelin integrated density (green) increased in all treated groups compared to the MS group. DAPI (blue) is used for nuclear counterstaining. MS, Multiple sclerosis; MBP, myelin basic protein; DAPI: 4’, 6-diamidino-2-phenylindole. The effect of bromelain and hADSCs on inflammatory factors The findings showed that pre-inflammatory cytokine serum levels (IFN-γ and interleukin-17 (IL-17)) in the MS group were significantly higher compared to the treated groups (Fig. 8A and B). In addition, the serum levels of TGF-β and IL-10, the anti-inflammatory agents, showed a significant increase in all treated groups compared to the MS group, especially in the MS/Stem group (Fig. 8C and D). Furthermore, the serum levels of IL-10 and TGF-β were significantly higher in the control and sham groups than in the cuprizone group (MS). Also, all the treated groups indicated a significant reduction in IgG levels in comparison with the MS group (Fig. 9). ELISA test to assess the mean serum level of inflammatory markers, including (A and B) IFN-γ and IL-17, and anti-inflammatory markers, including (C and D) TGF-β and IL-10. The results are presented as the mean ± SEM, n = 8. *P < 0.05 and **P < 0.01 indicate significant differences compared to the MS group. MS, Multiple sclerosis; IFN-γ, interferon gamma; IL, interleukin; TGF-β, transforming growth factor beta. ELISA test to assess serum IgG levels. The results are presented as the mean ± SEM, n = 8. *P < 0.05 and **P < 0.01 indicate significant differences compared to the MS group. MS, Multiple sclerosis; IgG, immunoglobulin G. DISCUSSION MS is one of the most common chronic diseases that damages the central nervous system, causing progressive destruction of myelin due to oligodendrocyte cell death. This abnormal condition causes plaque formation in the CNS, which induces severe physical or cognitive disability by disrupting the transmission of nerve messages(3841). There is currently no definitive cure for MS(424344). Drugs commonly used to treat MS are based on suppressing inflammation and modulating the immune system, including mitoxantrone and IFN-β. These drugs not only cannot stop the continuous progress in the destruction of nerve tissue, but also are not effective in the treatment of various types of MS(37). According to studies carried out in subsequent years, it has been found that stem cells, together with natural compounds that have neuroprotective properties, can be used as a new approach in the treatment of this disease(4546). Bromelain has been considered a natural compound in many studies due to its anti-inflammatory, antioxidant, and neuroprotective properties(244748). So far, many studies have been conducted on the impact of natural compounds and different stem cell types, including ADSCs, bone marrow-derived stem cells (BMSCs), hematopoietic stem cells (HSCs), and neural precursor cells (NPCs), to treat medical diseases and disorders(49). Among these cells, ADSCs have special characteristics such as the ability to differentiate into oligodendrocyte cells, and therefore provide a good justification for their use in the treatment of MS(16). Different animal models of MS are used to study oligo dendrocyte differentiation processes and the demyelination and remyelination processes. Although established animal models have their own advantages and disadvantages, no model completely reproduces the disease stages of MS. Experimental autoimmune encephalomyelitis (EAE) is widely considered a good model for testing immunosuppressive therapeutic agents. However, due to the limitations of establishing this model, the present study used the compound cuprizone to establish the MS model. In the present study, it was found that transplantation of hADSCs accompanied by bromelain coadministration led to increased myelin regeneration and improved motor function in mice. Previous studies have shown that hADSCs have many biological effects, such as neuroprotective(50), anti-inflammatory(51), and immunomodulatory(52). In addition, bromelain has similar effects to hADSCs(525354). Therefore, the simultaneous use of these two agents is expected to have synergistic effects. As indicated in Fig. 4A and B, stem cell transplantation combined with bromelain application increased the mean percentage of Olig2- and Mog-positive cells. This observation can be explained by the fact that hADSCs may directly differentiate into oligodendrocytes due to the neuroprotective, anti-inflammatory, and immunomodulatory effects of bromelain, and thus increase the population of PKH26/Olig2 and PKH26/Mog-positive markers. In addition, hADSCs may indirectly promote endogenous oligodendrogenesis by secreting neurotrophic factors. As a result, an increase in the population of oligodendrocytes and myelin production will lead to improved nerve signal transmission speed and increased sensory-motor activities. Overall, the increased myelin density and improved motor function of mice reported in this study (Figs. 3, 4C) could be due to an increase in myelin-producing cells and thus the promotion of myelin synthesis. In line with the results of the present study, the following studies can be mentioned. Bakhtiari et al. reported that hADSCs can largely differentiate into oligodendrocyte progenitor cells and therefore can be considered a suitable source of oligodendrocytes(37). Talwadekar et al. reported that transplantation of hADSCs in the MS model mice resulted in improved motor coordination and balance, as well as spinal myelination(53). Additionally, Killer et al. demonstrated that intravenous injection of ADSCs can lead to increased remyelination in the CC region(54). Another study by Yousefi et al. indicated that transplantation of hADSCs in the EAE model mice significantly increased the number of Olig2-positive cells and MBP, which aligns with our study despite differences in disease models(55). As shown in Fig. 3, cuprizone gavage significantly reduced the time mice spent hanging and maintaining balance. In justification of this issue, it can be said that cuprizone causes metabolic stress in oligodendrocyte cells by disrupting the function of mitochondrial enzymes(56). With the onset of oligodendrocyte death, the myelin sheath surrounding axons is destroyed, disrupting nerve impulse transmission and resulting in symptoms such as numbness and decreased muscle contractility. On the other hand, as can be seen in Fig. 6, cuprizone played an important role in increasing serum IgG levels. This increase could play an important role in the destruction of myelin tissue by forming immune complexes and causing cytotoxicity. Figure 6 shows that serum IgG levels significantly decreased in the groups receiving bromelain. Also, the duration of hanging in the mice in the groups receiving bromelain significantly increased compared to the cuprizone group. In justification of these results, it can be said that bromelain, as a strong immunosuppressant, has inhibitory effects on lymphocyte activity(57), and this can lead to a decrease in the secretion of immunoglobulins from B-lymphocyte cells. On the other hand, bromelain, due to its neuroprotective effects by increasing neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and strong antioxidant effects, can prevent oligodendrocyte cell death by activating cell signaling pathways such as PI3K/Akt and MAPK(58). An experimental study demonstrated that bromelain, by increasing serum levels of BDNF, can be beneficial in preventing memory decline in people with Parkinson’s disease(59). Bedel et al., in a mouse model of depression, showed that BDNF exerts neuroprotective effects by activating the PI3K/Akt signaling pathway(60). In addition, other laboratory studies revealed that bromelain can suppress inflammation in dental pulp stem cells and in RAW264.7 cells by inhibiting the MAPK-signaling pathways(6162). Therefore, preserving the myelin sheath and preventing oligodendrocyte cell death has increased muscle contractile strength and maintained motor balance in mice. Inflammation plays an important role in the pathophysiology of many chronic diseases, such as MS(58). Following the use of cuprizone, proinflammatory factors, including IFN-gamma and IL-17, significantly increased. In addition, serum levels of anti-inflammatory cytokines significantly increased in the groups that used bromelain. In justification of these results, it can be said that bromelain reduced neuroinflammation by reducing proinflammatory cytokines and neutralizing the effects of cuprizone. Also, bromelain improves mitochondrial function in nerve cells by neutralizing free radicals and increasing endogenous antioxidant enzymes. Therefore, bromelain is likely to suppress oligodendrocyte apoptosis and nerve damage through its anti-inflammatory and antioxidant activities(63). In a previous study, the use of bromelain has been particularly noted for preventing memory loss in Parkinson’s disease patients(64). Additionally, this compound can reduce the toxic effects of 6-hydroxydopamine hydrobromide (6-OHDA) in an experimental Parkinson’s disease model under in vitro conditions, with neuroprotective effects(47). Furthermore, its neuroprotective effects have been demonstrated both alone and combined with donepezil in an animal model of Alzheimer’s disease(48). CONCLUSION Based on the findings of this study, it can be concluded that transplantation of hADSCs combined with bromelain administration can promote remyelination and improve motor balance function. This may be due to the neuroprotective, anti-inflammatory, immunomodulatory, and oligodendrocyte differentiation-inducing effects of this compound on stem cells. However, the exact mechanism of these effects requires further investigation. Authors’ contributions N. Ghasemi designed the project. Sh. Rahnama wrote the manuscript, carried out the experiment, analyzed the data, designed the tables, and illustrated the figures. N. Ghasemi revised and edited the manuscript. N. Ghasemi had full access to the data in the study and final responsibility for the decision to submit for publication. All authors have read and approved the finalized article. Each author has fulfilled the authorship criteria and affirmed that this article represents honest and original work. Conflict of interest statement All authors declared no conflict of interest in this study. AI assistance statement AI-assisted design tools were employed for the preparation of the graphical abstract followed by manual refinement by the authors. Data availability The data supporting the findings of this study are documented and available from the corresponding author upon reasonable request. Researchers interested in accessing the data should contact the corresponding author to discuss the terms and conditions of access. Ethical approval This experimental study was conducted on the female C57BL/6 mouse model of MS at the Central Laboratory of Isfahan University of Medical Sciences. Meanwhile, all procedures of research were conducted according to the guidelines of the Iranian Committee of Animal Care approved by the Ethics Committee (Ethics#IR.MUI.AEC.1402.073).